elexxion AG (E8X) AI Stock Analysis
elexxion AG
(Munich:E8X)
No summary available
elexxion AG (E8X) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 1.06M
- Dividend Yield
- ―
- Average Volume (3M)
- 5,703
- Price to Earnings (P/E)
- -1.4
- Beta (1Y)
- -0.28
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Germany
- Employees
- 9
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
elexxion AG Business Overview & Revenue Model
Company Description
elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. The company offers dental diode lasers under the elexxion pico, elexxion nano, and elexxion claros names; and elexxion pico lite, a so...
elexxion AG Peers Comparison
Overall Rating
DE:EUZ69Neutral
DE:DRW365Neutral
DE:GME51Neutral
DE:AAQ140Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | EUR 832.23M | 16.63 | 19.49% | 1.65% | 4.42% | 35.68% | |
| 65Neutral | EUR 1.64B | 11.28 | 10.20% | 2.23% | 5.06% | 40.18% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 51Neutral | EUR 11.71M | -15.40 | -4.38% | 4.65% | 1.58% | -148.73% | |
| 40Underperform | EUR 21.34M | -7.44 | -32.36% | ― | 1.81% | 42.09% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:E8X | elexxion AG | 0.01 | -0.13 | -90.71% | |
| DE:AAQ1 | aap Implantate | 1.45 | -0.01 | -0.68% | |
| DE:DRW3 | Draegerwerk AG & Co. KGaA | 102.00 | 31.82 | 45.34% | |
| DE:EUZ | Eckert & Ziegler Strahlen und Medizintechnik | 13.30 | -3.09 | -18.88% | |
| DE:GME | Geratherm Medical | 2.15 | -1.52 | -41.40% | |
| DE:PHH2 | PAUL HARTMANN AG | 188.50 | -31.61 | -14.36% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.